Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Mar. 31, 2019 | Jul. 15, 2019 | Sep. 30, 2018 | |
Document And Entity Information | |||
Entity Registrant Name | Cyberfort Software, Inc. | ||
Entity Central Index Key | 0001522787 | ||
Document Type | 10-K | ||
Document Period End Date | Mar. 31, 2019 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --03-31 | ||
Is Entity a Well-known Seasoned Issuer? | No | ||
Is Entity a Voluntary Filer? | No | ||
Is Entity's Reporting Status Current? | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Public Float | $ 0 | ||
Entity Common Stock, Shares Outstanding | 33,758,612 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2019 | ||
Entity Shell Company | false | ||
Is Entity Emerging Growth Company? | false | ||
Entity Small Business | true |
Balance Sheets
Balance Sheets - USD ($) | Mar. 31, 2019 | Mar. 31, 2018 |
Current assets | ||
Cash | $ 652 | |
Total current assets | 652 | |
TOTAL ASSETS | 652 | |
Current liabilities | ||
Accounts payable | 147,789 | 115,841 |
Accrued expense | 282,257 | 399,907 |
Stock payable | 50,000 | 100,000 |
Notes payable - convertible | 95,604 | 52,441 |
Note payable | 135,000 | 150,000 |
Total current liabilities | 710,650 | 818,189 |
Total liabilities | 710,650 | 818,189 |
Commitments | ||
Stockholders' deficit: | ||
Common stock, $0.001 par value - 100,000,000 share authorized, 33,758,612 shares issued and outstanding at March 31, 2019 and 8,612 at March 31, 2018 | 33,759 | 9 |
Additional paid-in capital | 4,068,440 | 3,338,626 |
Accumulated deficit | (4,812,849) | (4,156,172) |
Total stockholders' deficit | (710,650) | (817,537) |
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT | $ 652 |
Balance Sheets (Parenthetical)
Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2019 | Mar. 31, 2018 |
Stockholders' Equity | ||
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 33,758,612 | 8,612 |
Common stock, shares outstanding | 33,758,612 | 8,612 |
Statements of Operations
Statements of Operations - USD ($) | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Statements Of Operations | ||
Net revenue | ||
Operating expenses: | ||
General and admin. expenses | 186,762 | 186,596 |
Conversion of accrued compensation | 344,285 | |
Stock compensation expense | 50,000 | 50,000 |
Total operating expenses | 581,047 | 236,596 |
Loss from operations | (581,047) | (236,596) |
Other (expenses)/income | ||
Interest Expense | (75,630) | (1,028) |
Net loss | $ (656,677) | $ (237,624) |
Loss per common share - basic and diluted | $ (0.02) | $ (27.71) |
Weighted average common shares outstanding - basic and diluted | 30,830,694 | 8,576 |
Statement of Stockholders' Defi
Statement of Stockholders' Deficit - USD ($) | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Total |
Beginning Balance, Amount at Mar. 31, 2017 | $ 9 | $ 3,272,426 | $ (3,918,548) | $ (646,113) |
Beginning Balance, Shares at Mar. 31, 2017 | 8,576 | |||
Issuance of common stock for cash, Amount | 66,200 | 66,200 | ||
Issuance of common stock for cash, Shares | 36 | |||
Net loss | (237,624) | (237,624) | ||
Ending Balance, Amount at Mar. 31, 2018 | $ 9 | 3,338,626 | (4,156,172) | (817,537) |
Ending Balance, Shares at Mar. 31, 2018 | 8,612 | |||
Issuance of common stock for repayment to officer for accrued compensation and accrued stock payable, Amount | $ 30,000 | 648,814 | 678,814 | |
Issuance of common stock for repayment to officer for accrued compensation and accrued stock payable, Shares | 30,000,000 | |||
Issuance of common stock for note conversion, Amount | $ 3,750 | 81,000 | 84,750 | |
Issuance of common stock for note conversion, Shares | 3,750,000 | |||
Net loss | (656,677) | (656,677) | ||
Ending Balance, Amount at Mar. 31, 2019 | $ 33,759 | $ 4,068,440 | $ (4,812,849) | $ (710,650) |
Ending Balance, Shares at Mar. 31, 2019 | 33,758,612 |
Statements of Cash Flows
Statements of Cash Flows - USD ($) | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Cash flows from operating activities: | ||
Net loss | $ (656,677) | $ (237,624) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Stock based compensation | 50,000 | 50,000 |
Loss on conversion of accrued compensation | 344,285 | |
Debt conversion expense | 69,750 | |
Changes in operating assets and liabilities: | ||
Prepaid expenses | 4,167 | |
Accounts payable | 31,948 | 7,917 |
Accrued expenses | 116,879 | 113,128 |
Net cash used in operating activities | (43,815) | (62,412) |
Cash flows from investing activities: | ||
Net cash provided by investing activities | ||
Cash flows from financing activities: | ||
Proceeds from Notes Payable | 43,163 | 54,140 |
Payment of principle on Notes Payable | (1,700) | |
Issuance of common stock for cash | 66,200 | |
Stock Subscription Payable | (60,000) | |
Net cash provided by financing activities | 43,163 | 58,640 |
Net change in cash | (652) | (3,772) |
Cash at the beginning of the period | 652 | 4,424 |
Cash at the end of the period | 652 | |
Supplemental disclosures of cash flow information: | ||
Cash paid for income taxes | ||
Cash paid for interest | 0 | 0 |
Non-cash investing and financing transactions: | ||
Common stock issued for conversion of note payable | $ 15,000 |
ORGANIZATION
ORGANIZATION | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 1 - ORGANIZATION | Cyberfort Software, Inc. (formerly known as Patriot Berry Farms, Inc.) (Cyberfort or “The “Company”) was incorporated in the State of Nevada on December 15, 2010 under the name of Gaia Remedies, Inc. On September 26, 2016, the board of directors and the majority shareholders of the Patriot Berry Farms, Inc. approved an amendment to the Articles of Incorporation of the Company to change its name from Patriot Berry Farms, Inc. to Cyberfort Software, Inc. Cyberfort is in the business of developing, marketing, and acquiring software security technology. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES | USE OF ESTIMATES The preparation of the Company’s financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. FAIR VALUE MEASUREMENT Our financial instruments consist principally of accounts payable and accrued liabilities and notes payable. The carrying amounts of such financial instruments in the accompanying financial statements approximate their fair values due to their relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments. INCOME TAXES The Company accounts for income taxes under FASB ASC 740 “Income Taxes.” STOCK-BASED COMPENSATION The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50 “Equity - Based Payments to Non-Employees.” a b RESEARCH AND DEVELOPMENT COSTS The Company expenses the cost of research and development as incurred. Research and development costs totaled approximately $3,000 and $0 for the years ended March 31, 2019 and 2018, respectively. NET INCOME OR (LOSS) PER SHARE OF COMMON STOCK The Company has adopted ASC 260 “Earnings per Share,” The Company has no potentially dilutive securities, such as options or warrants, currently issued and outstanding. |
GOING CONCERN
GOING CONCERN | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 3 - GOING CONCERN | The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As of March 31, 2019 and 2018, the Company has an accumulated deficit of $4,812,849 and $4,156,172. The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the next twelve months. The ability of the Company to emerge from the development stage is dependent upon, among other things, obtaining additional financing to continue operations. In response to this and other potential problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 4 - RELATED PARTY TRANSACTIONS | As of March 31, 2019 and March 31, 2018, the Company did not have any related party transactions, respectively. |
NOTES PAYABLE
NOTES PAYABLE | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 5 - NOTES PAYABLE | The Company assumed a non-interest bearing note payable to Mistrin of $150,000 with a maturity date of March 18, 2017 as a part of the acquisition of the Vivio App in September 2016. On June 19, 2018, $5,000 of the note was converted into 1,250,000 shares of the Company’s common stock. On July 31, 2018, $5,000 of the note was converted into 1,250,000 shares of the Company’s common stock. On October 11, 2018, $5,000 of the note was converted into 1,250,000 shares of the Company’s common stock. As of March 31, 2019, the balance of the note was $135,000. The note is in default. The Company is negotiating with the note holder to amend the note’s terms. |
CONVERTIBLE NOTES PAYABLE
CONVERTIBLE NOTES PAYABLE | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 6 - CONVERTIBLE NOTES PAYABLE | On October 4, 2017, the Company entered into an unsecured convertible loan agreement for $12,500 with an interest rate of 8% per annum and a maturity date of October 3, 2018. The loan is convertible into the Company’s common stock at the market value on the date of conversion. This note is in default. On November 10, 2017, the Company entered into an unsecured convertible loan agreement for $5,466 with an interest rate of 8% per annum and a maturity date of November 9, 2018. The loan is convertible into the Company’s common stock at the market value on the date of conversion. This note is in default. On November 24, 2017, the Company entered into an unsecured convertible loan agreement for $1,700 with an interest of 8% per annum and a maturity date of November 23, 2018. The loan is convertible into the Company’s common stock at the market value on at the date of conversion. The loan was paid in full during the prior year. On December 14, 2017, the Company entered into an unsecured convertible loan agreement for $13,300 with an interest rate of 8% per annum and a maturity date of December 13, 2018. The loan is convertible into the Company’s common stock at the market value on the date of conversion. This note is in default. On January 24, 2018, the Company entered into an unsecured convertible loan agreement for $3,000 with an interest rate of 8% per annum and a maturity date of January 23, 2019. The loan is convertible into the Company’s common stock at the market value on the date of conversion. This note is in default. On February 13, 2018, the Company entered into an unsecured convertible loan agreement for $11,000 with an interest rate of 8% per annum and a maturity date of February 12, 2019. The loan is convertible into the Company’s common stock at the market value on the date of conversion. This note is in default. On March 26, 2018, the Company entered into an unsecured convertible loan agreement for $2,200 with an interest rate of 8% per annum and a maturity date of March 25, 2019. The loan is convertible into the Company’s common stock at the market value on the date of conversion. This note is in default. On March 31, 2018, the Company entered into an unsecured convertible loan agreement for $4,974 with an interest rate of 8% per annum and a maturity date of March 30, 2019. The loan is convertible into the Company’s common stock at the market value on the date of conversion. This note is in default. On June 28, 2018, the Company entered into an unsecured convertible loan agreement for $18,540 with an interest rate of 8% per annum and a maturity date of June 27, 2019. The loan is convertible into the Company’s common stock at the market value on the date of conversion. This note is in default subsequent to year end. On September 28, 2018, the Company entered into an unsecured convertible loan agreement for $15,890 with an interest rate of 8% per annum and a maturity date of September 27, 2019. The loan is convertible into the Company’s common stock at the market value on the date of conversion. On December 12, 2018, the Company entered into an unsecured convertible loan agreement for $1,000 with an interest rate of 8% per annum and a maturity date of December 11, 2019. The loan is convertible into the Company’s common stock at the market value on the date of conversion. On December 31, 2018, the Company entered into an unsecured convertible loan agreement for $6,612 with an interest rate of 8% per annum and a maturity date of January 1, 2020. The loan is convertible into the Company’s common stock at the market value on the date of conversion. Notes payable - convertible totaled $95,604 and $52,441 at March 31, 2019 and 2018, respectively. |
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 7 - STOCKHOLDERS' EQUITY | On April 19, 2018, the Company underwent a reverse stock split at a ratio of 10,000 to 1 share, reducing the issued and outstanding shares from 86,123,796 to 8,612 shares issued and outstanding as of the date of the reverse split. All share amounts in these financial statements and footnotes reflect the reverse stock split. On April 19, 2018, the Company issued 30,000,000 shares, post-split, to the Company’s President as repayment for accrued compensation and accrued stock payable. On June 19, 2018, the Company issued 1,250,000 shares of its common stock for conversion of a note payable. On July 31, 2018, the Company issued 1,250,000 shares of its common stock for conversion of a note payable. On October 11, 2018, the Company issued 1,250,000 shares of its common stock for conversion of a note payable. Under the employment agreement with the CEO, the Company is required to grant shares of restricted stock after each anniversary date. At March 31, 2019 and March 31, 2018, the company has accrued a stock payable for shares earned but not issued of $50,000 and $100,000, respectively. The number of shares will be determined based upon market value of the stock at the point in time of issuance. |
COMMITMENTS
COMMITMENTS | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 8 - COMMITMENTS | On September 28, 2016, the Company entered into four consulting agreements with consultants to act in the role of Technology Development Manager, Chief Technology Officer, Corporate Development Officer, and Advisory Director and to provide consulting services as part of the Purchase and Sale Agreement with Mistrin. The term of the agreements shall be one year and shall be a rolling contract until terminated or extended. The Company shall issue each consultant a total of 200,000 shares of common stock per annum to a total of 800,000 shares per annum. The consulting agreements can be terminated after 90 days by either party for any reason and the consultant is entitled to receive the entire consideration. The 800,000 shares due under these consulting agreements were issued during the year ended March 31, 2018 and the contracts have been cancelled. The Company has a $54,000 commitment to provide developing and marketing costs related to the acquisition of the Vivio Application. |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 9 - INCOME TAXES | We did not provide any current or deferred U.S. federal income tax provision or benefit for any of the periods presented because we have experienced operating losses since inception. When it is more likely than not that a tax asset cannot be realized through future income the Company must allow for this future tax benefit. We provided a full valuation allowance on the net deferred tax assets, consisting of net operating loss carryforwards and intangible assets, because management has determined that it is more likely than not that we will not earn income sufficient to realize the deferred tax assets during the carryforward period. The Company has not taken a tax position that, if challenged, would have a material effect on the financial statements for the years ended March 31, 2019 and 2018, respectively, under ASC 740. We did not recognize any adjustment to the liability for uncertain tax position and therefore did not record any adjustment to the beginning balance of accumulated deficit on the balance sheet. The Company is subject to United States income taxes at a rate of 21%. Operating loss carry forwards totaled approximately $2,576,239 and $1,972,000, as of March 31, 2019 and 2018, respectively, and will begin to expire in 2032. The Company has not complied with annual filings of federal tax returns and accordingly utilization on the NOL may be impaired. Deferred tax assets of approximately $1,144,000 and $760,000, respectively, were offset by a valuation allowance. Actual income tax expense for the years ended March 31, 2019 and 2018 is reconcile 2019 2018 Expected tax benefit $ (137,300 ) $ (81,000 ) Reconciling items: Impact in change in tax rate - 31,000 Permanent Differences Stock compensation 10,500 17,000 Change in Valuation Allowance 126,800 33,000 Total tax expense $ - $ - |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
NOTE 10 - SUBSEQUENT EVENTS | On June 27, 2019, the unsecured convertible loan agreement for $18,540 with an interest rate of 8% per annum that is convertible into the Company’s common stock at the market value on the date of conversion was in default. On June 30, 2019, the Company entered into an unsecured convertible loan agreement for $12,437 with an interest rate of 8% per annum and a maturity date of June 29, 2020. The loan is convertible into the Company’s common stock at the market value on the date of conversion. |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Mar. 31, 2019 | |
Significant Accounting Policies | |
USE OF ESTIMATES | The preparation of the Company’s financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. |
FAIR VALUE MEASUREMENT | Our financial instruments consist principally of accounts payable and accrued liabilities and notes payable. The carrying amounts of such financial instruments in the accompanying financial statements approximate their fair values due to their relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments. |
INCOME TAXES | The Company accounts for income taxes under FASB ASC 740 "Income Taxes." |
STOCK-BASED COMPENSATION | The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50 “Equity - Based Payments to Non-Employees.” a b |
RESEARCH AND DEVELOPMENT COSTS | The Company expenses the cost of research and development as incurred. Research and development costs totaled approximately $3,000 and $0 for the years ended March 31, 2019 and 2018, respectively. |
NET INCOME OR (LOSS) PER SHARE OF COMMON STOCK | The Company has adopted ASC 260 “Earnings per Share,” The Company has no potentially dilutive securities, such as options or warrants, currently issued and outstanding. |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Mar. 31, 2019 | |
Income Taxes | |
Schedule of income tax expense | 2019 2018 Expected tax benefit $ (137,300 ) $ (81,000 ) Reconciling items: Impact in change in tax rate - 31,000 Permanent Differences Stock compensation 10,500 17,000 Change in Valuation Allowance 126,800 33,000 Total tax expense $ - $ - |
ORGANIZATION (Details Narrative
ORGANIZATION (Details Narrative) | 12 Months Ended |
Mar. 31, 2019 | |
Organization | |
Date of Incorporation | Dec. 15, 2010 |
State of Incorporation | Nevada |
SIGNIFICANT ACCOUNTING POLICI_3
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Significant Accounting Policies Details Narrative | ||
Research and development costs | $ 3,000 | $ 0 |
GOING CONCERN (Details Narrati
GOING CONCERN (Details Narrative) - USD ($) | Mar. 31, 2019 | Mar. 31, 2018 |
Going Concern | ||
Accumulated Deficit | $ (4,812,849) | $ (4,156,172) |
NOTES PAYABLE (Details Narrativ
NOTES PAYABLE (Details Narrative) - USD ($) | Oct. 11, 2018 | Jul. 31, 2018 | Jun. 19, 2018 | Mar. 31, 2019 | Mar. 31, 2018 |
Notes payable balance | $ 135,000 | $ 150,000 | |||
Debt conversion, converted instrument, amount | $ 5,000 | $ 5,000 | $ 5,000 | 15,000 | |
Debt conversion, converted instrument, shares issued | 1,250,000 | 1,250,000 | 1,250,000 | ||
Vivio App [Member] | |||||
Notes payable balance | $ 150,000 | ||||
Maturity date | Mar. 18, 2017 |
CONVERTIBLE NOTES PAYABLE (Deta
CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($) | Dec. 12, 2018 | Dec. 14, 2017 | Nov. 10, 2017 | Oct. 04, 2017 | Dec. 31, 2018 | Sep. 28, 2018 | Jun. 28, 2018 | Mar. 31, 2018 | Mar. 26, 2018 | Feb. 13, 2018 | Jan. 24, 2018 | Nov. 24, 2017 | Mar. 31, 2019 |
Notes payable - convertible | $ 52,441 | $ 95,604 | |||||||||||
Unsecured convertible loan agreement [Member] | |||||||||||||
Convertible debt | $ 1,000 | $ 13,300 | $ 5,466 | $ 12,500 | $ 6,612 | $ 15,890 | $ 18,540 | $ 4,974 | $ 2,200 | $ 11,000 | $ 3,000 | $ 1,700 | |
Interest rate | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | |
Maturity date | Dec. 11, 2019 | Dec. 13, 2018 | Nov. 9, 2018 | Oct. 3, 2018 | Jan. 1, 2020 | Sep. 27, 2019 | Jun. 27, 2019 | Mar. 30, 2019 | Mar. 25, 2019 | Feb. 12, 2019 | Jan. 23, 2019 | Nov. 23, 2018 | |
Notes payable - convertible | $ 52,441 | $ 95,604 |
STOCKHOLDERS_ EQUITY (Details N
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($) | Oct. 11, 2018 | Jul. 31, 2018 | Jun. 19, 2018 | Apr. 19, 2018 | Mar. 31, 2019 | Mar. 31, 2018 |
Reverse stock split description | 10,000 to 1 share | |||||
Revised shares after reverse stock splits | 8,612 | |||||
Common stock, shares issued | 33,758,612 | 8,612 | ||||
Common stock, shares outstanding | 33,758,612 | 8,612 | ||||
Debt conversion, converted instrument, shares issued | 1,250,000 | 1,250,000 | 1,250,000 | |||
Stock payable | $ 50,000 | $ 100,000 | ||||
President [Member] | ||||||
Common stock issued for compensation and accrued stock payable | 30,000,000 |
COMMITMENTS (Details Narrative)
COMMITMENTS (Details Narrative) - USD ($) | 1 Months Ended | |
Sep. 28, 2016 | May 31, 2019 | |
Term of consulting agreement | 1 year | |
Common stock, shares issuable under agreement | 800,000 | |
Terms and conditions of agreement | The consulting agreements can be terminated after 90 days by either party for any reason and the consultant is entitled to receive the entire consideration. | |
Commitments | $ 54,000 | |
Technology development manager [Member] | Consulting agreement [Member] | ||
Common stock, shares issuable under agreement | 200,000 | |
Chief technology officer [Member] | Consulting agreement [Member] | ||
Common stock, shares issuable under agreement | 200,000 | |
Corporate development officer [Member] | Consulting agreement [Member] | ||
Common stock, shares issuable under agreement | 200,000 | |
Advisory director [Member] | Consulting agreement [Member] | ||
Common stock, shares issuable under agreement | 200,000 |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Income Taxes Details | ||
Expected tax benefit | $ (137,300) | $ (81,000) |
Reconciling items: | ||
Impact in change in tax rate | 31,000 | |
Permanent Differences Stock compensation | 10,500 | 17,000 |
Change in Valuation Allowance | 126,800 | 33,000 |
Total tax expense |
INCOME TAXES (Details Narrative
INCOME TAXES (Details Narrative) - USD ($) | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Income Taxes Details Narrative | ||
Net operating loss carry forwards | $ (2,576,239) | $ (1,972,000) |
Operating loss carry forwards expire period | 2032 | |
Deferred tax assets | $ 1,144,000 | $ 760,000 |
SUBSEQUENT EVENTS (Details Narr
SUBSEQUENT EVENTS (Details Narrative) - Unsecured convertible loan agreement [Member] - USD ($) | Dec. 12, 2018 | Dec. 14, 2017 | Nov. 10, 2017 | Oct. 04, 2017 | Jun. 30, 2019 | Jun. 27, 2019 | Dec. 31, 2018 | Sep. 28, 2018 | Jun. 28, 2018 | Mar. 31, 2018 | Mar. 26, 2018 | Feb. 13, 2018 | Jan. 24, 2018 | Nov. 24, 2017 |
Interest rate | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | 8.00% | ||
Debt maturity date | Dec. 11, 2019 | Dec. 13, 2018 | Nov. 9, 2018 | Oct. 3, 2018 | Jan. 1, 2020 | Sep. 27, 2019 | Jun. 27, 2019 | Mar. 30, 2019 | Mar. 25, 2019 | Feb. 12, 2019 | Jan. 23, 2019 | Nov. 23, 2018 | ||
Subsequent Event [Member] | ||||||||||||||
Convertible debt | $ 12,437 | $ 18,540 | ||||||||||||
Interest rate | 8.00% | 8.00% | ||||||||||||
Debt maturity date | Jun. 29, 2020 |